Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Migraine Drugs Market size was over USD 6.22 billion in 2024 and is projected to reach USD 25.91 billion by 2037, growing at around 11.6% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of migraine drugs is assessed at USD 6.83 billion.
The major key factors projected to drive the growth of the market include rise in the prevalence of migraines, stressed lifestyle along with rising healthcare expenditure. Since, numbers of migraine incidences are increasing and order to meet the unmet demand in migraine drugs, most of the companies are investing in research and development areas pertaining to migraine drugs. Further, novel product innovations and development of new devices for the new treatment options for migraine is anticipated to accelerate the growth of the market over the forecast period.
